Related Experiment Video
Updated: Dec 21, 2025

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
Published on: August 4, 2012
Systematic Review of Methemoglobinemia in Acetaminophen Poisoning
Kamal Kant Sahu1, Susan V George1, Ahmad Daniyal Siddiqui2
1Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts, United States.
Background:
Acetaminophen (N-acetyl-para-aminophenol, paracetamol, (APAP) toxicity is one of the commonly encountered poisonings by emergency physicians. Methemoglobinemia is an uncommon association and rarely seen in APAP poisoning.
Methods:
Retrospective analysis of all the published reports on APAP induced methemoglobinemia from 1968 to 2019.
Results:
In total there were 14 cases with 9 females and 6 males. The median age of the study cohort was 59 years. The most common presenting feature was altered mentation (9 patients) followed by cyanosis (3 patients). The intent of consumption was therapeutic (7 cases) versus suicidal (5 cases) attempt.In most cases, the dose of APAP consumption was not known. Aspirin, sulfasalazine, benzocaine spray, nitrate preservative, contaminated water, detergents, etc. where the other agents consumed by the patients in addition to APAP before developing methemoglobinemia. The median MethHb level of the study cohort was 15.85% Patients were treated with NAC, hemodialysis, methylene blue, and ascorbic acid and CRRT in various combinations. Full recovery was seen in 9 patients while 4 patients died.
Conclusion:
APAP toxicity is a well-known and common entity with multiple sequelae that presents with a variable spectrum of mild to fulminant multiorgan failure. Awareness of non-classical presentations like methemoglobinemia is essential to ensure timely intervention.
Insights
Acetaminophen (APAP) poisoning can rarely cause methemoglobinemia. Early recognition of this uncommon complication is crucial for prompt medical intervention and improved patient outcomes.
Area of Science:
- Toxicology
- Emergency Medicine
- Clinical Pathology
Background:
- Acetaminophen (APAP) toxicity is a frequent emergency department presentation.
- Methemoglobinemia is an infrequent but serious complication of APAP overdose.
Purpose of the Study:
- To review and analyze published cases of acetaminophen-induced methemoglobinemia.
- To highlight the clinical features, management, and outcomes of this rare condition.
Main Methods:
- A retrospective analysis of published case reports from 1968 to 2019.
- Inclusion criteria focused on cases of methemoglobinemia associated with APAP ingestion.
Main Results:
- 14 cases were identified (9 female, 6 male), with a median age of 59.
- Altered mentation and cyanosis were common presentations; median methemoglobin level was 15.85%.
- Treatments included NAC, hemodialysis, methylene blue; 9 patients recovered, 4 died.
Conclusions:
- Acetaminophen toxicity can present with diverse and severe complications.
- Methemoglobinemia is a critical, non-classical presentation of APAP toxicity requiring heightened clinical awareness.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Prevention of Further Absorption of Poison
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

